 SOLANA BEACH, Calif., March 01, 2022 GLOBE NEWSWIRE -- Evoke Pharma, Inc. NASDAQ: EVOK, a specialty pharmaceutical company focused on treatments for gastrointestinal GI diseases, today announced that the Company is scheduled to release its fourth quarter and full year 2021 financial results on Tuesday, March 8, 2022, after the market closes. 